Pantoprazol Reig Jofre (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Reig Jofre, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Reig Jofre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. - Gastro‑oesophageal reflux disease (GERD): Improves symptom control and promotes healing of the oesophageal lining. - Erosive esophagitis: Facilitates healing of erosions caused by acid exposure. - Peptic ulcer disease: Supports ulcer healing and reduces recurrence risk.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild and transient. - Diarrhea: usually self‑limiting. - Nausea: occasional mild upset. - Abdominal pain: mild cramping. - Flatulence: increased gas. - Constipation: occasional bowel change.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile infection: may cause severe colitis. - Low magnesium levels (hypomagnesemia): can lead to muscle cramps or arrhythmia. - Bone fractures: long‑term use linked to reduced bone density. - Liver enzyme elevation: indicates possible hepatic stress.

Before initiating therapy, consider the following safety points: - Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor for infection risk: prolonged acid suppression can increase gastrointestinal infection susceptibility. - Evaluate bone health: long‑term therapy may affect calcium absorption. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole may interact with several medicines; monitoring is recommended.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption and efficacy. - HIV protease inhibitors (ritonavir, lopinavir): decreased plasma levels of the antiviral. - Clopidogrel: diminished antiplatelet effect, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Methotrexate: reduced renal clearance may raise toxicity risk. - Digoxin: slight increase in serum concentrations; observe for toxicity signs.